HomeCompareHTBX vs GBDC

HTBX vs GBDC: Dividend Comparison 2026

HTBX yields 84.03% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $18.87M in total portfolio value· pulled ahead in Year 8
10 years
HTBX
HTBX
● Live price
84.03%
Share price
$2.38
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.98M
Annual income
$593,470.68
Full HTBX calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — HTBX vs GBDC

📍 GBDC pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHTBXGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HTBX + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HTBX pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HTBX
Annual income on $10K today (after 15% tax)
$7,142.86/yr
After 10yr DRIP, annual income (after tax)
$504,450.08/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, GBDC beats the other by $13,478,673.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HTBX + GBDC for your $10,000?

HTBX: 50%GBDC: 50%
100% GBDC50/50100% HTBX
Portfolio after 10yr
$11.42M
Annual income
$8,522,102.26/yr
Blended yield
74.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on HTBX right now

HTBX
Analyst Ratings
8
Buy
Consensus: Buy
Altman Z
-22.5
Piotroski
2/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HTBX buys
0
GBDC buys
0
No recent congressional trades found for HTBX or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHTBXGBDC
Forward yield84.03%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$1.98M$20.85M
Annual income after 10y$593,470.68$16,450,733.83
Total dividends collected$1.73M$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: HTBX vs GBDC ($10,000, DRIP)

YearHTBX PortfolioHTBX Income/yrGBDC PortfolioGBDC Income/yrGap
1$19,103$8,403.36$12,492$1,791.70+$6.6KHTBX
2$35,444$15,003.03$16,527$3,160.58+$18.9KHTBX
3$63,940$26,014.99$23,588$5,904.90+$40.4KHTBX
4$112,276$43,860.35$37,141$11,901.65+$75.1KHTBX
5$192,114$71,978.72$66,205$26,463.38+$125.9KHTBX
6$320,666$115,104.62$137,452$66,612.65+$183.2KHTBX
7$522,671$179,557.63$342,372$195,298.53+$180.3KHTBX
8← crossover$832,781$273,523.56$1,053,292$686,954.33$220.5KGBDC
9$1,298,375$407,299.36$4,111,439$2,984,416.95$2.81MGBDC
10$1,982,732$593,470.68$20,849,974$16,450,733.83$18.87MGBDC

HTBX vs GBDC: Complete Analysis 2026

HTBXStock

Heat Biologics, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which has completed enrollment in a Phase II clinical trial to treat patients with advanced non-small cell lung cancer; and HS-130 that is in Phase I clinical trial for the treatment of advanced solid tumors. Its products also include PTX-35, a novel T-cell co-stimulator agonist antibody targeting DR3/TNFRSF25 that is in Phase I clinical trial; DR3/TNFRSF25 for various immunotherapy approaches; and COVID-19 vaccine, which is in preclinical stage. Heat Biologics, Inc. has a collaboration with Dr. James Shapiro at University of Alberta to manufacture surrogate mouse version of PTX-35. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina.

Full HTBX Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this HTBX vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HTBX vs SCHDHTBX vs JEPIHTBX vs OHTBX vs KOHTBX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.